Tag: hairy cell leukaemia

US approves AZ’ hairy cell leukaemia drug

by Selina McKee | Sep 14, 2018 | News | 0

AstraZeneca and its biologics R&D arm MedImmune have bagged US approval of Lumoxiti for the treatment of hairy cell leukaemia (HCL), marking the first new treatment option in 20 years.

Priority review for AZ’ hairy cell leukaemia drug

by Selina McKee | Apr 4, 2018 | News | 0

US regulators have assigned priority review status to AstraZeneca and MedImmune’s moxetumomab pasudotox, which is being developed as a treatment for hairy cell leukaemia (HCL).